Still on antithrombotic therapy after intracerebral hemorrhage.Intracerebral hemorrhage attributable to preceding head injury, hemorrhagic transformation of an ischemic stroke, or intracranial hemorrhage without intracerebral hemorrhage.Survived ≥24 hours after spontaneous intracerebral hemorrhage, confirmed by brain imaging, and were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease at the onset of intracerebral hemorrhage, after which therapy was discontinued.
Eligible patients were randomized in a 1:1 fashion to either resume antiplatelet therapy (n = 268) or avoid antiplatelet therapy (n = 269).
0 kommentar(er)
